Evidence map›Paper›PMID 37575555›Full record

ArticleJournal of registry management2023

Assessing Completeness of Cancer Treatment Data from an Academic Medical Center's Tumor Registry Through Comparison to the Central Registry.

Bradley D McDowell, Suzanne E Bentler, Michele M West, Amanda R Kahl, Sarah H Nash, Jason T Brubaker, Bobbi Matt, Mary E Charlton

Open access · greenAbstract read
In one paragraph

Article in Journal of registry management, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bradley D McDowellUniversity of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa.
Suzanne E BentlerUniversity of Iowa Department of Epidemiology, Iowa Cancer Registry, Iowa City, Iowa.
Michele M WestUniversity of Iowa Department of Epidemiology, Iowa Cancer Registry, Iowa City, Iowa.
Amanda R KahlUniversity of Iowa Department of Epidemiology, Iowa Cancer Registry, Iowa City, Iowa.
Sarah H NashUniversity of Iowa Department of Epidemiology, Iowa Cancer Registry, Iowa City, Iowa.
Jason T BrubakerUniversity of Iowa Department of Epidemiology, Iowa Cancer Registry, Iowa City, Iowa.
Bobbi MattUniversity of Iowa Department of Epidemiology, Iowa Cancer Registry, Iowa City, Iowa.
Mary E CharltonUniversity of Iowa Department of Epidemiology, Iowa Cancer Registry, Iowa City, Iowa.
University of Iowa Holden Comprehensive Cancer Center

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Building a patient-centered cancer data mart in a rural stateR50CA243692 · NCI · UNIVERSITY OF IOWA · PI MCDOWELL, BRADLEY D · 2019 to 2023
$490k
NCI NIH HHS P30 CA086862NCI NIH HHS R50 CA243692
6 · The paper itself

Abstract

Background: Researchers often rely on hospital tumor registry data to provide comprehensive cancer therapy information. The purpose of this study was to determine the completeness of treatment information found in the abstracted records of patients seen at an academic medical center located in a rural Midwestern state. Approach: The cohort included 846 Iowa residents diagnosed with a single malignant tumor of the female breast, colon/rectum, lung, pancreas, or prostate in 2017-2018 with an abstract recorded by the academic medical center and at least 1 other hospital. Treatment/no treatment agreement between the academic medical center's abstract and the central registry's consolidated abstract was examined for the following summary variables of the North American Association of Central Cancer Registries (NAACCR): surgery of the primary site, chemotherapy, radiation therapy, immunotherapy, and hormone therapy. Treatment summary variables from the academic medical center abstract that agreed with the corresponding variables from the central registry abstract were classified as Results: There was high concordance between the treatment information recorded in the academic medical center and the central registry records. The average proportion of treatment/no treatment agreement across all treatment modalities and cancer sites was 0.97 (SD, 0.02). Concordance remained high even when examining specific treatments (average concordance, 0.95; SD, 0.04). The lowest treatment/no treatment concordance proportion was 0.92 (95% CI, 0.86-0.96) for chemotherapeutic treatment of pancreatic cancer. We also found that the academic medical center's summary variables captured most treatments given at other facilities, ranging from 74.4% capture of immunotherapy to 88.2% capture of surgery of the primary site. Conclusions: These results indicate that NAACCR-formatted, summary variables from the academic medical center's tumor registry are likely to provide comprehensive treatment information for those individuals diagnosed or treated in this setting. Analyses of either the academic medical record registry records or consolidated records from the central registry should yield similar results. Future research should establish whether similar findings are obtained at other medical centers.

Indexed as

Medical RecordsPancreatic NeoplasmsAcademic Medical CentersFemaleHumansMaleRacial GroupsRegistriesacademic medical centercancerregistrytreatment

Identifiers

PMID37575555
PMCPMC10414202
OpenAlexW4385798988

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.